Clinical Trial Update: To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of R2R01 in combination with standard of care versus standard of care alone in outpatients with wors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• R2R01 (R2R01)

Snippet

Sponsor: River 2 Renal Corp. | Conditions: Heart Failure, Worsening Heart Failure (WHF) | Phase 2 | Status: COMPLETED